Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

Summary

This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo as adjunctive therapy to GAD treatment in patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria for GAD who have an inadequate response to ongoing GAD treatment.

Timeline

Start

2024-08-05

Primary completion

2027-06

Completion

2027-06

Drugs

Indications